Enseval Putera Megatrading Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enseval Putera Megatrading Tbk PT with three other
drug stores in Asia:
Guangxi Liuzhou Pharmaceutical Co Ltd
sales of 7.56 billion Chinese Renmimbi [US$1.12 billion]
of which 92%
Cachet Pharmaceutical Company., Limited
(10.97 billion Chinese Renmimbi [US$1.63 billion]
of which 100%
was Commerce), and
Luyan Pharma Co Ltd
based in China
(6.98 billion Chinese Renmimbi [US$1.04 billion]
of which 95%
was Pharmaceutical Wholesale).
Enseval Putera Megatrading Tbk PT reported sales of 18.93 trillion Indonesian Rupiahs (US$1.42 billion)
December of 2016.
increase of 8.4%
versus 2015, when the company's sales were 17.47 trillion Indonesian Rupiahs.
Sales at Enseval Putera Megatrading Tbk PT have increased during each of the previous five years
(and since 2011, sales have increased a total of 78%).
Sales of Other saw an increase
11.7% in 2016, from
2.47 trillion Indonesian Rupiahs to 2.76 trillion Indonesian Rupiahs.